$BJCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOJECT MEDICAL TECHNOLOGIES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOJECT MEDICAL TECHNOLOGIES INC. Get notifications about new insider transactions in BIOJECT MEDICAL TECHNOLOGIES INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 1.37 | 656,306 | 899,139 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 1.37 | 207,255 | 283,939 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 0.01 | 23,095 | 173 | 23,095 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 0.13 | 82,900 | 10,777 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 1.37 | 1,820,483 | 2,494,062 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 1.15 | 1,770,073 | 2,035,584 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 0.01 | 4,135 | 31 | 4,135 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 0.13 | 14,821 | 1,927 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 1.37 | 325,908 | 446,494 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | C | 1.15 | 316,884 | 364,417 | 0 | |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 656,306 | 0 | 656,306 | 0 to 656.3 K |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 207,255 | 0 | 207,255 | 0 to 207.3 K |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 8,290,002 | 0 | 11,962,566 | 3.7 M to 12 M (+225.73 %) |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 1,820,483 | 0 | 3,672,564 | 1.9 M to 3.7 M (+98.29 %) |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 1,770,073 | 0 | 1,852,081 | 82 K to 1.9 M (+2,158.42 %) |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 1,482,067 | 0 | 2,139,543 | 657.5 K to 2.1 M (+225.42 %) |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 325,908 | 0 | 657,473 | 331.6 K to 657.5 K (+98.29 %) |
| Jun 05 2014 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Buy | C | 0.00 | 316,884 | 0 | 331,565 | 14.7 K to 331.6 K (+2,158.46 %) |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and CMO | Option Exercise | C | 0.75 | 11,700 | 8,775 | 0 | |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and CMO | Buy | C | 0.75 | 11,700 | 8,775 | 551,390 | 539.7 K to 551.4 K (+2.17 %) |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | Vice President of F ... | Option Exercise | C | 0.75 | 11,700 | 8,775 | 0 | |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | Vice President of F ... | Buy | C | 0.75 | 11,700 | 8,775 | 422,457 | 410.8 K to 422.5 K (+2.85 %) |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Option Exercise | C | 0.75 | 78,400 | 58,800 | 0 | |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Buy | C | 0.75 | 78,400 | 58,800 | 156,400 | 78 K to 156.4 K (+100.51 %) |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | P | 0.08 | 6,176,800 | 463,260 | 10,041,657 | |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | C | 0.13 | 547,220 | 71,139 | 0 | |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | C | 0.75 | 784,200 | 588,150 | 0 | |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Buy | C | 0.13 | 547,220 | 71,139 | 2,947,580 | 2.4 M to 2.9 M (+22.80 %) |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Buy | C | 0.75 | 784,200 | 588,150 | 2,400,360 | 1.6 M to 2.4 M (+48.52 %) |
| Jun 03 2014 | BJCT | BIOJECT MEDICAL TE ... | Logomasini Mark | President and CEO | Option Exercise | P | 0.08 | 8,287,467 | 621,560 | 13,524,753 | |
| Feb 20 2013 | BJCT | BIOJECT MEDICAL TE ... | Logomasini Mark | President & CEO | Option Exercise | A | 0.06 | 2,000,000 | 120,000 | 2,045,000 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 13.00 | 15,258 | 198,354 | 65,593 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 13.00 | 2,732 | 35,516 | 13,473 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 1.37 | 48,615 | 66,603 | 607,691 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 1.37 | 15,352 | 21,032 | 207,255 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 1.37 | 45,104 | 61,792 | 559,076 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 137.00 | 14,215 | 1,947,455 | 191,903 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 1.37 | 134,698 | 184,536 | 1,818,423 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 1.37 | 24,114 | 33,036 | 325,539 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 1.37 | 124,720 | 170,866 | 1,683,725 | |
| Feb 19 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 1.37 | 22,328 | 30,589 | 301,425 | |
| Feb 06 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | P | 0.04 | 63,612 | 2,226 | 63,612 | |
| Feb 06 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | P | 0.04 | 11,388 | 399 | 11,388 | |
| Feb 05 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 13.00 | 44,323 | 576,199 | 44,323 | |
| Feb 05 2013 | BJCT | BIOJECT MEDICAL TE ... | LIFE SCIENCES OPPORTUNITIES FU ... | 10% Owner | Option Exercise | J | 13.00 | 9,665 | 125,645 | 9,665 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | Logomasini Mark | CEO/President | Option Exercise | P | 0.04 | 3,192,285 | 111,730 | 3,192,285 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | Logomasini Mark | CEO/President | Option Exercise | D | 0.19 | 78,948 | 15,000 | 0 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | Logomasini Mark | CEO/President | Option Exercise | P | 0.19 | 39,474 | 7,500 | 78,948 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | P | 0.04 | 3,794,857 | 132,820 | 5,072,557 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | D | 0.19 | 52,632 | 10,000 | 0 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | P | 0.19 | 26,316 | 5,000 | 52,632 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | Hansen Albert | Director | Option Exercise | D | 0.19 | 78,948 | 15,000 | 0 | |
| Jan 28 2013 | BJCT | BIOJECT MEDICAL TE ... | Hansen Albert | Director | Option Exercise | P | 0.19 | 39,474 | 7,500 | 78,948 | |
| Jan 04 2012 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 04 2012 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and Chief Medic ... | Buy | M | 0.00 | 25,000 | 0 | 417,341 | 392.3 K to 417.3 K (+6.37 %) |
| Jan 04 2012 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 04 2012 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 25,000 | 0 | 318,024 | 293 K to 318 K (+8.53 %) |
| Jul 01 2011 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | P | 0.19 | 13,158 | 2,500 | 19,825 | |
| Jul 01 2011 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | P | 0.19 | 26,316 | 5,000 | 92,983 | |
| Jul 01 2011 | BJCT | BIOJECT MEDICAL TE ... | Logomasini Mark | Director | Option Exercise | P | 0.19 | 39,474 | 7,500 | 39,474 | |
| Jul 01 2011 | BJCT | BIOJECT MEDICAL TE ... | Hansen Albert | Director | Option Exercise | P | 0.19 | 39,474 | 7,500 | 39,474 | |
| Feb 01 2011 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | M | 0.00 | 50,000 | 0 | 50,000 | |
| Feb 01 2011 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Buy | M | 0.00 | 50,000 | 0 | 877,368 | 827.4 K to 877.4 K (+6.04 %) |
| Jan 04 2011 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 39,000 | 0 | 483,831 | |
| Jan 04 2011 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and Chief Medic ... | Buy | M | 0.00 | 39,000 | 0 | 392,341 | 353.3 K to 392.3 K (+11.04 %) |
| Jan 04 2011 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 39,000 | 0 | 461,421 | |
| Jan 04 2011 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 39,000 | 0 | 293,024 | 254 K to 293 K (+15.35 %) |
| Dec 13 2010 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Option Exercise | A | 0.08 | 20,000 | 1,600 | 70,000 | |
| Dec 13 2010 | BJCT | BIOJECT MEDICAL TE ... | Cobbs Jerald S | Director | Option Exercise | A | 0.08 | 20,000 | 1,600 | 60,000 | |
| Dec 13 2010 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | A | 0.08 | 20,000 | 1,600 | 70,000 | |
| Oct 04 2010 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | M | 0.00 | 33,334 | 0 | 50,000 | |
| Oct 04 2010 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Buy | M | 0.00 | 33,334 | 0 | 827,368 | 794 K to 827.4 K (+4.20 %) |
| Jun 14 2010 | BJCT | BIOJECT MEDICAL TE ... | Hansen Albert | Director | Option Exercise | A | 0.15 | 55,000 | 8,250 | 55,000 | |
| Jun 14 2010 | BJCT | BIOJECT MEDICAL TE ... | Cobbs Jerald S | Director | Option Exercise | A | 0.15 | 40,000 | 6,000 | 40,000 | |
| Jun 14 2010 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | A | 0.15 | 330,000 | 49,500 | 330,000 | |
| Jun 14 2010 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Grant | A | 0.00 | 400,000 | 0 | 794,034 | 394 K to 794 K (+101.51 %) |
| Jun 11 2010 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and Chief Medic ... | Option Exercise | A | 0.15 | 270,000 | 40,500 | 535,331 | |
| Jun 11 2010 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Option Exercise | A | 0.15 | 50,000 | 7,500 | 124,267 | |
| Jun 11 2010 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | A | 0.15 | 50,000 | 7,500 | 50,000 | |
| Jun 11 2010 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | A | 0.15 | 240,000 | 36,000 | 509,171 | |
| Apr 26 2010 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP and Chief Medic ... | Option Exercise | A | 0.30 | 150,000 | 45,000 | 265,331 | |
| Apr 26 2010 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | A | 0.30 | 150,000 | 45,000 | 269,171 | |
| Jun 11 2010 | BJCT | BIOJECT MEDICAL TE ... | Logomasini Mark | Director | Option Exercise | A | 0.15 | 45,000 | 6,750 | 45,000 | |
| Feb 01 2010 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | M | 0.00 | 50,000 | 0 | 307,601 | |
| Feb 01 2010 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Buy | M | 0.00 | 50,000 | 0 | 394,034 | 344 K to 394 K (+14.53 %) |
| Jan 04 2010 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 24,000 | 0 | 164,796 | |
| Jan 04 2010 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 24,000 | 0 | 225,443 | 201.4 K to 225.4 K (+11.91 %) |
| Jan 04 2010 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Option Exercise | M | 0.00 | 24,000 | 0 | 160,956 | |
| Jan 04 2010 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Buy | M | 0.00 | 24,000 | 0 | 328,341 | 304.3 K to 328.3 K (+7.89 %) |
| Dec 21 2009 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | A | 0.13 | 384,600 | 49,998 | 1,127,267 | |
| Dec 08 2009 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | M | 0.00 | 33,333 | 0 | 357,601 | |
| Dec 08 2009 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Buy | M | 0.00 | 33,333 | 0 | 344,034 | 310.7 K to 344 K (+10.73 %) |
| Dec 08 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | P | 0.00 | 5,000 | 0 | 188,796 | |
| Dec 08 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 5,000 | 0 | 201,443 | 196.4 K to 201.4 K (+2.55 %) |
| Dec 08 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Option Exercise | M | 0.00 | 5,000 | 0 | 184,956 | |
| Dec 08 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Buy | M | 0.00 | 5,000 | 0 | 304,341 | 299.3 K to 304.3 K (+1.67 %) |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Option Exercise | M | 0.00 | 36,000 | 0 | 74,267 | |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Buy | M | 0.00 | 36,000 | 0 | 78,000 | 42 K to 78 K (+85.71 %) |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | RUEDY JOHN | Director | Option Exercise | M | 0.00 | 19,000 | 0 | 36,000 | |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | RUEDY JOHN | Director | Buy | M | 0.00 | 19,000 | 0 | 104,810 | 85.8 K to 104.8 K (+22.14 %) |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Makes Brigid | Director | Option Exercise | M | 0.00 | 21,000 | 0 | 0 | |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Makes Brigid | Director | Buy | M | 0.00 | 21,000 | 0 | 68,000 | 47 K to 68 K (+44.68 %) |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 742,667 | |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Buy | M | 0.00 | 18,000 | 0 | 1,537,526 | 1.5 M to 1.5 M (+1.18 %) |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Cobbs Jerald S | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Cobbs Jerald S | Director | Buy | M | 0.00 | 18,000 | 0 | 211,377 | 193.4 K to 211.4 K (+9.31 %) |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | CHASE RANDAL D | Director | Option Exercise | M | 0.00 | 19,000 | 0 | 0 | |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | CHASE RANDAL D | Director | Buy | M | 0.00 | 19,000 | 0 | 92,500 | 73.5 K to 92.5 K (+25.85 %) |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Bohan Joseph Francis | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
| Jun 09 2009 | BJCT | BIOJECT MEDICAL TE ... | Bohan Joseph Francis | Director | Buy | M | 0.00 | 18,000 | 0 | 67,000 | 49 K to 67 K (+36.73 %) |
| Mar 10 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Option Exercise | M | 0.00 | 25,000 | 0 | 189,956 | |
| Mar 10 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Buy | M | 0.00 | 25,000 | 0 | 284,341 | 259.3 K to 284.3 K (+9.64 %) |
| Feb 02 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Option Exercise | M | 0.00 | 75,000 | 0 | 214,956 | |
| Feb 02 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Buy | M | 0.00 | 75,000 | 0 | 259,341 | 184.3 K to 259.3 K (+40.69 %) |
| Mar 10 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 25,000 | 0 | 193,796 | |
| Mar 10 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 25,000 | 0 | 196,443 | 171.4 K to 196.4 K (+14.58 %) |
| Feb 02 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 75,000 | 0 | 218,796 | |
| Feb 02 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 75,000 | 0 | 171,443 | 96.4 K to 171.4 K (+77.77 %) |
| Jan 20 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Option Exercise | M | 0.00 | 834 | 0 | 289,956 | |
| Jan 20 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Buy | M | 0.00 | 834 | 0 | 184,341 | 183.5 K to 184.3 K (+0.45 %) |
| Jan 20 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | Vp of Finance | Option Exercise | M | 0.00 | 834 | 0 | 293,796 | |
| Jan 20 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | Vp of Finance | Buy | M | 0.00 | 834 | 0 | 96,443 | 95.6 K to 96.4 K (+0.87 %) |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 24,000 | 0 | 294,630 | |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 24,000 | 0 | 95,609 | 71.6 K to 95.6 K (+33.52 %) |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 24,000 | 0 | 294,630 | |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 24,000 | 0 | 95,609 | 71.6 K to 95.6 K (+33.52 %) |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Option Exercise | P | 0.00 | 24,000 | 0 | 290,790 | |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Buy | M | 0.00 | 24,000 | 0 | 183,507 | 159.5 K to 183.5 K (+15.05 %) |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | M | 0.00 | 50,000 | 0 | 390,934 | |
| Jan 02 2009 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Buy | M | 0.00 | 50,000 | 0 | 295,701 | 245.7 K to 295.7 K (+20.35 %) |
| Dec 10 2008 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Option Exercise | M | 0.00 | 5,000 | 0 | 318,630 | |
| Dec 10 2008 | BJCT | BIOJECT MEDICAL TE ... | FARRELL CHRISTINE | VP of Finance | Buy | M | 0.00 | 5,000 | 0 | 71,609 | 66.6 K to 71.6 K (+7.51 %) |
| Dec 10 2008 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Option Exercise | M | 0.00 | 5,000 | 0 | 314,790 | |
| Dec 10 2008 | BJCT | BIOJECT MEDICAL TE ... | STOUT RICHARD | EVP/Chief Medical O ... | Buy | M | 0.00 | 5,000 | 0 | 159,507 | 154.5 K to 159.5 K (+3.24 %) |
| Dec 10 2008 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Option Exercise | M | 0.00 | 33,333 | 0 | 440,934 | |
| Dec 10 2008 | BJCT | BIOJECT MEDICAL TE ... | Makar Ralph | CEO/President | Grant | A | 0.00 | 33,333 | 0 | 245,701 | 212.4 K to 245.7 K (+15.70 %) |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 760,667 | |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | FLYNN EDWARD L | Director | Buy | M | 0.00 | 18,000 | 0 | 1,519,526 | 1.5 M to 1.5 M (+1.20 %) |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Option Exercise | M | 0.00 | 36,000 | 0 | 110,267 | |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Tierney David S | Director | Buy | M | 0.00 | 36,000 | 0 | 42,000 | 6 K to 42 K (+600.00 %) |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | RUEDY JOHN | Director | Option Exercise | M | 0.00 | 19,000 | 0 | 47,500 | |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | RUEDY JOHN | Director | Buy | M | 0.00 | 19,000 | 0 | 85,810 | 66.8 K to 85.8 K (+28.44 %) |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Makes Brigid | Director | Option Exercise | M | 0.00 | 21,000 | 0 | 21,000 | |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Makes Brigid | Director | Buy | M | 0.00 | 21,000 | 0 | 47,000 | 26 K to 47 K (+80.77 %) |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Cobbs Jerald S | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 18,000 | |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Cobbs Jerald S | Director | Buy | M | 0.00 | 18,000 | 0 | 193,377 | 175.4 K to 193.4 K (+10.26 %) |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | CHASE RANDAL D | Director | Option Exercise | M | 0.00 | 19,000 | 0 | 19,000 | |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | CHASE RANDAL D | Director | Buy | M | 0.00 | 19,000 | 0 | 73,500 | 54.5 K to 73.5 K (+34.86 %) |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Bohan Joseph Francis | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 18,000 | |
| Dec 09 2008 | BJCT | BIOJECT MEDICAL TE ... | Bohan Joseph Francis | Director | Buy | M | 0.00 | 18,000 | 0 | 49,000 | 31 K to 49 K (+58.06 %) |